Quick Answer
Arcadia Biosciences, Inc. reported Long Term Debt of $0.00 for the year ending 2021.
- Arcadia Biosciences, Inc. showed a decrease of -100.0% in Long Term Debt from 2020 to 2021.
- This data is from Arcadia Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
- XBRL data for this metric is available from 2016 to 2021 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $23.09 million | Q2 2017: $21.06 million | Q2 2020: $2.74 million | Q3 2020: $2.55 million | Q1 2021: $96.0 thousand | Q2 2021: $87.0 thousand | Q3 2021: $78.0 thousand.
- Over the full 4 years of available data (2016 to 2021), Arcadia Biosciences, Inc.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2021: $0.00 | Fiscal year 2020: $2.11 million | Fiscal year 2019: $107.0 thousand | Fiscal year 2016: $25.13 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: